Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenACWY conjugate vaccine memory B-cell response study in healthy infants
2006-003476-35Phase 2Completed
- Sponsor
- Novartis
- Start
- Mar 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Meningococcal ACWY conjugate vaccine in meningococcal disease and meningococcemia, sponsored by Novartis. Primary endpoint: Prediction of 12-month hSBA by post-primary memory B-cell frequency. Started Mar 2007; status: completed.
02
Drugs
Meningococcal ACWY conjugate vaccine
03
Conditions
meningococcal diseasemeningococcemia
Beyond the preview
Go deeper on 2006-003476-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003476-35.